24083-12-3

Upstream product

• 111-83-1 1-bromo-octane 
• 100-83-4 meta-hydroxybenzaldehyde 
• 111-85-3 n-chlorooctane 
• 111-87-5 octanol 

Downstream Products

• 307498-37-9 1-((E)-2-Methoxy-vinyl)-3-octyloxy-benzene 
• 77113-60-1 5-(3-(octyloxy)benzyl)pyrimidine-2,4-diamine 
• 307498-46-0 3-hydroxy-4-(3-octyloxy-phenyl)-butyric acid 
• 307498-43-7 1-(3-octyloxy-phenyl)-pent-4-en-2-ol 
• 307498-40-4 (3-octyloxy-phenyl)-acetaldehyde 
• 77113-65-6 (Z)-2-Methoxymethyl-3-(3-octyloxy-phenyl)-acrylonitrile 

Relevant academic research and scientific papers

Organic soluble indigoids derived from 3-hydroxybenzaldehyde for N-type organic field-effect transistor (OFET) applications

Two new series of organic soluble indigoids 7-7′-dialkoxyindigoids (2a, 2b) and 4,4′-dibromo-7,7′-dialkoxyindigoids (3a, 3b) (alkoxy = n-butoxy and n-octyloxy) were synthesized starting from the inexpensive 3-hydroxybenzaldehyde. The indigoids were solubl

Substitution of terminal amide with 1H-1,2,3-triazole: Identification of unexpected class of potent antibacterial agents

3-Methoxybenzamide (3-MBA) derivatives have been identified as novel class of potent antibacterial agents targeting the bacterial cell division protein FtsZ. As one of isosteres for the amide group, 1,2,3-triazole can mimic the topological and electronic features of the amide, which has gained increasing attention in drug discovery. Based on these considerations, we prepared a series of 1H-1,2,3-triazole-containing 3-MBA analogues via isosteric replacement of the terminal amide with triazole, which had increased antibacterial activity. This study demonstrated the possibility of developing the 1H-1,2,3-triazole group as a terminal amide-mimetic element which was capable of both keeping and modulating amide-related bioactivity. Surprisingly, a different action mode of these new 1H-1,2,3-triazole-containing analogues was observed, which could open new opportunities for the development of antibacterial agents.

Bicyclic heteroamatic compounds useful as LH agonists

The invention relates to a bicyclic heteroaromatic derivative compound according to general formula (I), or a pharmaceutically acceptable salt thereof, wherein R1is NR5R6, OR5, SR5or R7; R5and R6are independently selected from H, (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, alkyl(1-8C)carbonyl, (6-14C)arylcarbonyl, (6-14C)aryl or (4-13C)heteroaryl, or R5and R6together are joined in a (2-7C)heterocloalkyl ring; R7is (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, (6-14C)aryl or (4-13C)heteroaryl, R2is (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, or (6-14C)aryl or (4-13C)heteroaryl, both optionally substituted with one or more substituents selected from (1-8C)alkyl, (1-8C)alkylthio, (1-8C)(di)alkylamino, (1-8C)alkoxy, (2-8C)alkenyl, or (2-8C)alkynyl; R3is (1-8C)alkyl, (2-8C)alkenyl, (2-8C)alkynyl, (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, or (6-14C)aryl or (4-13C)heteroaryl, both optionally substituted with one or more substituents selected from (1-8C)alkyl, (1-8C)(di)alkylamino or (1-8C)alkoxy; X is S, O or N(R4); R4is H, (1-8C)alkyl, (1-8C)alkylcarbonyl, (6-14C)arylcarbonyl or (6-14C)aryl(1-8C)alkyl; Y is CH or N; Z is NH2or OH; A is S, N(H), N(R9), O or a bond; R9can be selected from the same groups as described for R2and B is N(H), O or a bond. The compounds of the invention have LH receptor activating activity and can be used in fertility regulating therapies.

Syntheses and antifungal activity of pseudomycin side-chain analogues. Part 1

We have described herein the syntheses of three novel series of aromatic ring containing pseudomycin side-chain analogues. Preliminary biological evaluations of these analogues clearly indicate that it is possible to synthesize rigid pseudomycin side-chain analogues without compromising in vitro antifungal activity. (C) 2000 Elsevier Science Ltd.

Antirhinovirus agents

Compounds of the following general structure are useful as antirhinovirus agents: STR1 wherein Y is a bond, oxygen or divalent sulfur; R is a straight or branched hydrocarbon chain having from 6 to 20 carbon atoms and is saturated or unsaturated having from 1 to 4 double bonds when R has from 10 to 20 carbon atoms and 1 or 2 double bonds when R has from 6 to 9 carbon atoms; and R1 is hydrogen or a straight or branched alkyl group of from 1 to 4 carbon atoms.